Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Long-term treatment with Fosrenol controls phosphate in end-stage renal disease

April 11, 2003

New series of PDE5 inhibitors in early development at Schering-Plough

April 11, 2003

Novel 5alpha-reductase inhibitors covered by Jenapharm patent

April 11, 2003

DA-8159 is well tolerated in healthy volunteers and without significant hemodynamic effects

April 8, 2003

Renagel receives NHI drug price listing in Japan

April 8, 2003

Sumitomo presents new muscarinic M3 antagonists for use in urinary incontinence

April 7, 2003

ACS news: inhibitors of phosphate transport for use in patients with chronic renal disease

April 2, 2003

Oxytocin agonists with utility in erectile dysfunction claimed by Ferring

April 1, 2003

BioXell commences phase II trial of BXL-628

March 31, 2003

Bayer presents novel VR1 antagonists for urinary incontinence, pain, etc.

March 26, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...